(Circulation. 1999;100:509-515.)
© 1999 American Heart Association, Inc.
Clinical Investigation and Reports |
From the Departments of Cardiology (Medizinische Klinikum Innenstadt) (C.H.S., V.K., H.M., S.D.S., A.R.T., J.R., K.-H.H., K.T., C.E.A.) and Cardiac Surgery (Klinikum Großhadern) (P.U., B.R.), and the Institute of Medical Informatics, Biometry, and Epidemiology (U.S.), University of Munich, Germany.
Correspondence to Christoph H. Spes, MD, Medizinische Klinikum Innenstadt, University of Munich, Ziemssenstraße 1, D-80336 München, Germany.
BackgroundRoutine methods for surveillance of cardiac allograft vasculopathy (CAV) are coronary angiography and intravascular ultrasound (IVUS). This study analyzed the diagnostic and prognostic value of dobutamine stress echocardiography (DSE) for noninvasive assessment of CAV.
Methods and ResultsIn 109 heart transplant recipients, 333
DSEs were compared with 285 coronary angiograms and 199 IVUS
analyses. Studies were repeated after 1, 2, 3, 4, and
5 years
in 88, 74, 37, 18, and 7 patients, respectively. Resting 2D
echocardiography detected CAV defined by IVUS and
angiography with a sensitivity of 57% (specificity 88%). DSE
increased the sensitivity to 72% (P=0.002). M-mode
analysis increased the sensitivity of 2D rest and stress
analysis (P=0.001, 0.004). Cardiac events
occurred after 1.9% of normal stress tests by 2D analysis
(combined 2D and M-mode: 0%), compared with 6.3% (3.8%) of normal
resting studies. Worsening of serial DSE indicated an increased risk of
events compared with no deterioration (relative risk 7.26,
P=0.0014). Serial deterioration detected by stress only
was associated with a higher risk of events than changes evident from
resting studies (relative risk 3.06, P=0.0374).
ConclusionsDSE identifies patients at risk for events and facilitates monitoring of CAV. A normal DSE predicts an uneventful clinical course and justifies postponement of invasive studies. The prognostic value of DSE is comparable to that of IVUS and angiography.
Key Words: transplantation coronary disease stress echocardiography
This article has been cited by other articles:
![]() |
J. D. Estep, D. J. Shah, S. F. Nagueh, J. J. Mahmarian, G. Torre-Amione, and W. A. Zoghbi The Role of Multimodality Cardiac Imaging in the Transplanted Heart J. Am. Coll. Cardiol. Img., September 1, 2009; 2(9): 1126 - 1140. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Schmauss and M. Weis Cardiac Allograft Vasculopathy: Recent Developments Circulation, April 22, 2008; 117(16): 2131 - 2141. [Abstract] [Full Text] [PDF] |
||||
![]() |
E Eroglu, J D'hooge, G R Sutherland, A Marciniak, D Thijs, W Droogne, L Herbots, J Van Cleemput, P Claus, B Bijnens, et al. Quantitative dobutamine stress echocardiography for the early detection of cardiac allograft vasculopathy in heart transplant recipients Heart, February 1, 2008; 94(2): e3 - e3. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. R. Bogot, R. Durst, D. Shaham, and D. Admon Cardiac CT of the Transplanted Heart: Indications, Technique, Appearance, and Complications RadioGraphics, September 1, 2007; 27(5): 1297 - 1309. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Tona, A. L.P. Caforio, R. Montisci, A. Gambino, A. Angelini, M. Ruscazio, G. Toscano, G. Feltrin, A. Ramondo, G. Gerosa, et al. Coronary Flow Velocity Pattern and Coronary Flow Reserve by Contrast-Enhanced Transthoracic Echocardiography Predict Long-Term Outcome in Heart Transplantation Circulation, July 4, 2006; 114(1_suppl): I-49 - I-55. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Romeo, L. Houyel, C.-Y. Angel, P. Brenot, J.-Y. Riou, and J.-F. Paul Coronary Stenosis Detection by 16-Slice Computed Tomography in Heart Transplant Patients: Comparison With Conventional Angiography and Impact on Clinical Management J. Am. Coll. Cardiol., June 7, 2005; 45(11): 1826 - 1831. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. D. Thompson, G. J. Balady, B. R. Chaitman, L. T. Clark, B. D. Levine, and R. J. Myerburg Task Force 6: Coronary artery disease J. Am. Coll. Cardiol., April 19, 2005; 45(8): 1348 - 1353. [Full Text] [PDF] |
||||
![]() |
U. Sechtem Do heart transplant recipients need annual coronary angiography? Eur. Heart J., June 1, 2001; 22(11): 895 - 897. [PDF] |
||||
![]() |
G.R Ciliberto, L Ruffini, M Mangiavacchi, M Parolini, R Sara, D Massa, R De Maria, E Gronda, E Vitali, and O Parodi Resting echocardiography and quantitative dipyridamole technetium-99m sestamibi tomography in the identification of cardiac allograft vasculopathy and the prediction of long-term prognosis after heart transplantation Eur. Heart J., June 1, 2001; 22(11): 964 - 971. [Abstract] [PDF] |
||||
![]() |
J. M. Aranda Jr. and J. Hill Cardiac Transplant Vasculopathy Chest, December 1, 2000; 118(6): 1792 - 1800. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. B. Young Allograft Vasculopathy : Diagnosing the Nemesis of Heart Transplantation Circulation, August 3, 1999; 100(5): 458 - 460. [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1999 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |